Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- ChecktodayChange DetectedNew update entries dated 2026-03-23, 2026-03-20, and 2026-03 were added. Older update entries dated 2026-03-02, 2026-02-27, and 2026-02 were removed.SummaryDifference0.2%

- Check8 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; it appears to be a backend/systems update with no visible changes to study details or navigation.SummaryDifference0.1%

- Check15 days agoChange DetectedFooter Revision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check22 days agoChange DetectedDuke Eye Center in Durham, NC was added to the study locations, bringing the total sites to 17 and the recruitment status to Recruiting.SummaryDifference0.5%

- Check36 days agoChange DetectedAdministrative updates show new update dates in February 2026 (2026-02-17, 2026-02-13, 2026-02) and corresponding deletions from January 2026 (2026-01-15, 2026-01-14, 2026-01). There is no evidence of changes to the study design, endpoints, eligibility criteria, enrollment, or recruitment locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site now displays Revision: v3.4.2, and the funding-status notice as well as the previous Revision: v3.4.1 text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.